Catheter Precision (VTAK) Net Cash Flow Growth (1y) (2018 - 2026)
Catheter Precision (VTAK) Net Cash Flow Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 176.81 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | -564.44% |
| 6 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | -394.13% |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn | -31.84% |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 76.43% |
| 10 | Catheter Precision | 608,890.64 | 208,890.64 | 390,000.00 | 114.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 114.57% |
| Dec 31, 2025 | -161.74% |
| Sep 30, 2025 | -81.15% |
| Jun 30, 2025 | 126.37% |
| Mar 31, 2025 | -16.83% |
| Dec 31, 2024 | 179.69% |
| Sep 30, 2024 | 168.38% |
| Jun 30, 2024 | 69.32% |
| Mar 31, 2024 | 43.04% |
| Dec 31, 2023 | -191.46% |
| Sep 30, 2023 | -172.40% |
| Jun 30, 2023 | 26.30% |
| Mar 31, 2023 | -239.66% |
| Dec 31, 2022 | 139.53% |
| Sep 30, 2022 | 538.64% |
| Jun 30, 2022 | -252.93% |
| Mar 31, 2022 | 132.78% |
| Dec 31, 2021 | 42.80% |
| Sep 30, 2021 | -90.72% |
| Jun 30, 2021 | -61.02% |